PATIENT INTERFACE
A patient interface comprises: a plenum chamber (3200) pressurisable to a therapeutic pressure above ambient air pressure, said plenum chamber including a plenum chamber inlet port sized and structured to receive a flow of air at the therapeutic pressure for breathing by a patient; a seal-forming st...
Saved in:
Main Authors | , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
16.03.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A patient interface comprises: a plenum chamber (3200) pressurisable to a therapeutic pressure above ambient air pressure, said plenum chamber including a plenum chamber inlet port sized and structured to receive a flow of air at the therapeutic pressure for breathing by a patient; a seal-forming structure (3100) constructed and arranged to seal with a region of the patient's face surrounding an entrance to the patient's airways, said seal-forming structure being constructed and arranged such that the flow of air at said therapeutic pressure is delivered to an entrance to the patient's nares, and the seal-forming structure being constructed and arranged to maintain said therapeutic pressure in the plenum chamber throughout the patient's respiratory cycle in use; a positioning and stabilising structure configured to hold the seal-forming structure in a therapeutically effective position on the patient's head, the positioning and stabilising structure comprising a tie, and the tie being constructed and arranged so that at least a portion overlies a region of the patient's head superior to an otobasion superior of the patient's head in use; and a vent structure formed in the plenum chamber and configured to allow a continuous flow of gases exhaled by the patient from an interior of the plenum chamber to ambient; wherein the patient interface is configured to leave the patient's mouth uncovered during therapy, wherein the seal-forming structure is shaped and dimensioned such that no portion of the seal-forming structure enters into the patient's nares during use, wherein the seal-forming structure (3100) comprises two lateral support regions (3112.3; 3117), each located at a lateralmost side of the seal-forming structure (3100), and a medial region (3112.1; 3113, 3115) positioned between the lateral support regions, the naris openings passing through the seal-forming structure at the medial region, wherein the lateral support regions (3112.3; 3117) are thicker than the medial region (3112.1; 3113, 3115), andwherein the seal-forming structure further comprises two mid-lateral regions (3112.2), each of the mid-lateral regions being positioned laterally outward from and adjacent to the medial region and medially inward from and adjacent to a corresponding one of the lateral support regions, the mid-lateral regions being thicker than the medial region and thinner than the lateral support regions. |
---|---|
Bibliography: | Application Number: EP20210184115 |